We are in the midst of the greatest technological revolution of all time. After years in its nascent stages, the internet has become a critical fixture in all aspects of our lives. High-tech turning high-touch, to borrow a phrase from futurist John Naisbitt, has become our reality. All one needs… Read More

The student threw his hands up in frustration. “Professor,” he said, “I just don’t get it.” He slumped in his chair totally defeated. #-ad_banner-#I understood the feeling. I had spent more than two hours explaining basic financial ideas to a college freshman. But try as I might, I couldn’t get… Read More

Advertising is timeless, which I find reassuring. Thousands of years ago, the ancient Egyptians painted sales notices on papyrus. In the middle ages, store proprietors employed town criers to help drum up business. And today’s store merchants are no different, doing whatever they can to showcase their wares and attract customers. #-ad_banner-#Why does that matter? Well, just ask anybody who invested in pocket pagers, answering machines or floppy disc drives. Technological advances can quickly render must-have products and services into obsolete relics. Even landline telephones, a revolutionary marvel in their day, are now facing slow extinction. But there will always… Read More

Advertising is timeless, which I find reassuring. Thousands of years ago, the ancient Egyptians painted sales notices on papyrus. In the middle ages, store proprietors employed town criers to help drum up business. And today’s store merchants are no different, doing whatever they can to showcase their wares and attract customers. #-ad_banner-#Why does that matter? Well, just ask anybody who invested in pocket pagers, answering machines or floppy disc drives. Technological advances can quickly render must-have products and services into obsolete relics. Even landline telephones, a revolutionary marvel in their day, are now facing slow extinction. But there will always be demand for advertising that helps connect buyers and sellers. Some of the biggest spenders include auto makers, wireless providers, drug companies and fast food chains. They are always communicating with consumers — and spending an extraordinary amount of money doing so.  This is a race — and taking your foot off the advertising pedal leaves many businesses at risk of being left in the dust by rivals.  That’s why so many spend a nickel or dime (or more) from every dollar of sales on marketing efforts. One of my favorites in the group collects steady income from big names… Read More

The casual dining sector has fallen on hard times. Hit by a triple whammy of consumer burnout, lack of innovation, and improving value and quality at fast food outlets, this once-thriving sector is in need of life support. #-ad_banner-#Despite a bustling economy, casual dining sales are forecasted to climb only… Read More

If you’re anything like me, you’re glad the holidays are over. Don’t get me wrong, taking a break from work and spending quality time with family is a good and necessary thing. But now it’s time to get back to business. Time to look forward. Time to plan for 2017 and beyond and navigate the challenges the market will likely bring. With this in mind, I recently came across an interesting trade that my colleague Jared Levy, Chief Investment Strategist of Profit Amplifier, shared with his readers… —Sponsored Link— BKIT Could Give… Read More

If you’re anything like me, you’re glad the holidays are over. Don’t get me wrong, taking a break from work and spending quality time with family is a good and necessary thing. But now it’s time to get back to business. Time to look forward. Time to plan for 2017 and beyond and navigate the challenges the market will likely bring. With this in mind, I recently came across an interesting trade that my colleague Jared Levy, Chief Investment Strategist of Profit Amplifier, shared with his readers… —Sponsored Link— BKIT Could Give You 200% Gains BEFORE February 1, 2017 With what could be the biggest breakthrough their industry has ever seen, little-known BKIT could have just supplanted the current king of sleep therapies, Ambien. Act now and you could see a fast 200% by February 1! See the proof HERE. Our Expert Is Starting The New Year With A Familiar Trade If you’ve been trading stocks for a while, then it’s very likely that you’ve developed certain “go-to” trades. These are the trades that, for some reason or other, you keep coming back to because they’re… Read More

Dow 20,000 is all anyone can talk about lately even though most people follow the S&P 500 more closely as a market proxy. And the milestone seems to be drawing closer; the market gave back some gains in the last few days of 2016 but investor enthusiasm for stocks is… Read More

Can Nvidia Corporation (Nasdaq: NVDA) stock, which could do no wrong last year, be trusted in 2017? And by “trust” I mean can the company live up to all of the hype investors have created? Notice that I didn’t say Nvidia itself has created the hype. Living Inside The Nvidia Bubble While the company’s entry into the realm of virtual and augmented reality, data centers, self-driving cars, and other growth markets were well-timed moves, the shares have approached bubble territory. And some investors still believe the stock — even after more than 200% returns — has room to run… Read More

Can Nvidia Corporation (Nasdaq: NVDA) stock, which could do no wrong last year, be trusted in 2017? And by “trust” I mean can the company live up to all of the hype investors have created? Notice that I didn’t say Nvidia itself has created the hype. Living Inside The Nvidia Bubble While the company’s entry into the realm of virtual and augmented reality, data centers, self-driving cars, and other growth markets were well-timed moves, the shares have approached bubble territory. And some investors still believe the stock — even after more than 200% returns — has room to run while ignoring the attractive short thesis the Nvidia story has created. #-ad_banner-#After crushing the Nasdaq 100 Index (NDX) with some 222% returns in 2016, the semiconductor company has a tough act to follow. That, however, hasn’t stopped retail investors from wanting to chase the returns they feel they’ve missed out on last year. Notably, on the heels of the stock soaring almost 35% in one month, analysts at Goldman Sachs added Nvidia to the Conviction Buy list. Who’s Left To Buy The Stock? But here’s the question Goldman — or any other long investor — must ask: Who’s left… Read More

As we enter 2017, between the incoming rate hikes and improved growth expectations, it looks as if new opportunities are developing among Real Estate Investment Trusts, or REITs. These stocks offer a simple way to invest in real estate for income as well as growth. REITs are designed to benefit from the attractive fundamentals of real estate, without saddling smaller investors with the high capital requirements and low liquidity of actual houses or other physical assets. Through various REITs, an investor can simultaneously become a landlord in an apartment complex 500 miles away, an owner of a high-end shopping center,… Read More

As we enter 2017, between the incoming rate hikes and improved growth expectations, it looks as if new opportunities are developing among Real Estate Investment Trusts, or REITs. These stocks offer a simple way to invest in real estate for income as well as growth. REITs are designed to benefit from the attractive fundamentals of real estate, without saddling smaller investors with the high capital requirements and low liquidity of actual houses or other physical assets. Through various REITs, an investor can simultaneously become a landlord in an apartment complex 500 miles away, an owner of a high-end shopping center, or a self-storage entrepreneur, without the hassle of actually running these businesses. A REIT structure allows investors to not only benefit from the long-term value appreciation of all these assets, but it also enables them to get their share of income. The high returns offered by some REITs fit perfectly with the goal of my premium newsletter, The Daily Paycheck: to provide my readers with fat monthly dividend checks. —Sponsored Link— Top 6 Ways To Invest in 2017 — No. 4 Will Surprise You Interested in gold stocks but unsure where the price is headed? … Read More

The pharmaceutical sector is well known as one of the most volatile and lucrative stock market sectors. It can also be the most emotionally rewarding, as you invest in companies that are creating innovative, life-saving treatments for various illnesses. #-ad_banner-#But with high returns come high risk, and the pharmaceutical sector’s reputation as one of the riskiest is well deserved. In fact, pharma’s inherent volatility can make it downright dangerous for investors. Share prices can quickly gain 100% on the back of the positive news or lose 50% or more in a short time when negative news hits the wire. The… Read More

The pharmaceutical sector is well known as one of the most volatile and lucrative stock market sectors. It can also be the most emotionally rewarding, as you invest in companies that are creating innovative, life-saving treatments for various illnesses. #-ad_banner-#But with high returns come high risk, and the pharmaceutical sector’s reputation as one of the riskiest is well deserved. In fact, pharma’s inherent volatility can make it downright dangerous for investors. Share prices can quickly gain 100% on the back of the positive news or lose 50% or more in a short time when negative news hits the wire. The key to success in pharmaceutical investing is to locate firms that are on the cutting edge of novel research and have multiple products in their pipeline. Ideally, you also want a company whose shares have recently taken a hit due to a short-term negative event that caused an investor overreaction. With these points in mind, I have located an ideal pharmaceutical stock that has been recently been pushed down, creating massive upside potential. The company, Alnylam (Nasdaq: ALNY), was founded in 2002 with a mandate to advance RNA interference (RNAi) as an entirely new class of medicines. RNAi is a… Read More